ProQR Therapeutics Provides Update on Ophthalmic Assets Press release LEIDEN, Netherlands & CAMBRIDGE, Mass., Sept. 27, 2023 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. septembre 27, 2023
ProQR Announces Virtual Presentations at Scientific Conferences Press release LEIDEN, Netherlands & CAMBRIDGE, Mass., Sept. septembre 24, 2020
ProQR to Present at Upcoming Scientific Conferences Press release LEIDEN, Netherlands and CAMBRIDGE, Mass., Nov. novembre 18, 2019
ProQR to Present at Upcoming Investor Conference Press release LEIDEN, the Netherlands, March 05, 2018 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. mars 05, 2018
ProQR Announces Virtual Presentation at EURETINA 2021 Press release LEIDEN, Netherlands & CAMBRIDGE, Mass., Sept. septembre 06, 2021
ProQR Announces Expert Perspectives Conference Call Series Press release Initial call in the series will feature Usher syndrome and retinitis pigmentosa on June 22 juin 12, 2020
ProQR to Present at Upcoming Investor Conferences Press release LEIDEN, Netherlands and CAMBRIDGE, Mass., Nov. novembre 13, 2019
ProQR Announces Extraordinary General Meeting of Shareholders Press release LEIDEN, the Netherlands, Dec. décembre 27, 2017
ProQR Announces Pricing of Initial Public Offering Press release LEIDEN, Netherlands, Sept. 18, 2014 (GLOBE NEWSWIRE) -- ProQR Therapeutics today announced the pricing of its initial public offering of 7,500,000 ordinary shares at an initial public offering price of $13.00 per ordinary share. septembre 18, 2014